Suven Pharmaceuticals announced that CRISIL has assigned/ reaffirmed the following ratings to the Bank facilities of the Company as under:
Long Term Rating - CRISIL A+/Watch Positive (Continues on 'Rating Watch with Positive Implications')
Short Term Rating - CRISIL A1+ (Reaffirmed)